Christofer Baldwin
Affiliation confirmed via AI analysis of OpenAlex, ORCID, and web sources.
Graduate Assistant
Unknown Researcher
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
Christofer Baldwin's research focuses on tissue engineering, particularly the development of strategies for skeletal and smooth muscle regeneration. His work has explored the use of stem cells, including satellite cells, in these regenerative medicine approaches. Baldwin has also investigated the challenges and prospects associated with engineering smooth muscle tissues. His publications include a 2024 review on smooth muscle tissue engineering and a 2022 paper on stem cell-based methods for skeletal muscle tissue engineering. He has also co-authored research on targeted drug delivery in cancer cells. Baldwin has collaborated with researchers from the University of Arkansas at Fayetteville and the University of Arkansas at Little Rock.
Metrics
- h-index: 2
- Publications: 4
- Citations: 5
Selected Publications
-
Evaluation of Human Stem Cell Conditioned Medium and Culture Conditions on Alleviating Elastase-Compromised Human Aortic Smooth Muscle Cell Function (2026)
-
Targeted Delivery of Rapamycin via Epidermal Growth Factor Receptors in Pancreatic Cancer Cells Inhibits Cell Proliferation and Induces Apoptosis (2025)
-
The Challenges and Prospects of Smooth Muscle Tissue Engineering (2024)
-
Stem cell‐based strategies for skeletal muscle tissue engineering (2022)
Collaboration Network
Top Collaborators
- Stem cell‐based strategies for skeletal muscle tissue engineering
- The Challenges and Prospects of Smooth Muscle Tissue Engineering
- Targeted Delivery of Rapamycin via Epidermal Growth Factor Receptors in Pancreatic Cancer Cells Inhibits Cell Proliferation and Induces Apoptosis
- Stem cell‐based strategies for skeletal muscle tissue engineering
- Stem cell‐based strategies for skeletal muscle tissue engineering
- The Challenges and Prospects of Smooth Muscle Tissue Engineering
- Targeted Delivery of Rapamycin via Epidermal Growth Factor Receptors in Pancreatic Cancer Cells Inhibits Cell Proliferation and Induces Apoptosis
- Targeted Delivery of Rapamycin via Epidermal Growth Factor Receptors in Pancreatic Cancer Cells Inhibits Cell Proliferation and Induces Apoptosis
- Targeted Delivery of Rapamycin via Epidermal Growth Factor Receptors in Pancreatic Cancer Cells Inhibits Cell Proliferation and Induces Apoptosis
- Targeted Delivery of Rapamycin via Epidermal Growth Factor Receptors in Pancreatic Cancer Cells Inhibits Cell Proliferation and Induces Apoptosis
- Targeted Delivery of Rapamycin via Epidermal Growth Factor Receptors in Pancreatic Cancer Cells Inhibits Cell Proliferation and Induces Apoptosis
- Targeted Delivery of Rapamycin via Epidermal Growth Factor Receptors in Pancreatic Cancer Cells Inhibits Cell Proliferation and Induces Apoptosis
Similar Researchers
Based on overlapping research topics